ASCO GI 2023 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO GI 2023 Conference Coverage

Videos

Playback speed

10 seconds

Phase 3 Randomized SUNLIGHT Study: Trifluridine/Tipiracil + Bevacizumab for 3L Treatment of Refractory mCRC

By ASCO GI 2023 Conference Coverage FEATURING Josep Tabernero

510 views

January 25, 2023

Disclaimer: This video was recorded prior to FDA approval of trifluridine and tipiracil with bevacizumab ...
read more ↘ on August 2, 2023 for mCRC.
↖ read less

0 Comments

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Videos